ArticleMedComm2026

Safety and Efficacy of Vedolizumab for the Patients With Gastrointestinal Acute Graft-Versus-Host Disease Refractory to Steroid Treatment After Allogeneic Hematopoietic Stem Cell Transplantation: A Real-World, Retrospective Multicenter Study (VAST Study).

Leqing Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.